Active Not RecruitingNCT06840379
Effect of Sertraline on Inflammation in Hemodialysis Patients with Depression: a Randomized Controlled Trial
Medication studyAges 18–65Pakistan
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- MultanSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: October 15, 2024
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 62
- Sponsor
- Nishtar Medical University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Locations
- Pakistan
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06840379
- Official title
Show the full official title
Effects of Sertraline on C-Reactive Protein Serum Levels in Hemodialysis Patients Diagnosed with Depression
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Multan
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Nishtar Medical University, a university.
Does this study involve medication?
Yes. The study involves medication, including Sertraline (Oral Antidepressant) and Placebo.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
